DAYAN RESEARCH

Independent research


Equity research on US small caps

Four companies per edition, each with an explicit call and a price target. Every figure recalculated from SEC filings. No positions held, no issuer compensation.

Readership
Portfolio managers, investment offices and family offices
Universe
Small and micro caps listed in the United States
Frequency
Two editions a month, on the 1st and the 15th
Horizon
12 to 18 months

Read the latest analysisSubscription and pricing

What you get

Research you can act on, checked line by line

Four companies per edition Each with an explicit call, Buy or Speculative, and a 12-to-18-month price target.
Figures from the filings Balance sheet, cash flow and dilution recalculated from Forms 10-Q and 10-K.
Every call tracked Each edition reports how past calls have done against the Russell 2000, losses included. Targets reached are published on this site.

From a recent edition

One company, as subscribers received it

Edition of November 1, 2026

Nature's Sunshine NASDAQ: NATR

Herbal nutritional supplements, sold in more than 40 countries

Buy

A profitable, debt-free company whose cash equals 38% of its market cap, valued at 2.5x EBITDA after a 56% drop since March.

$12.25Reference price, October 30 close
$15.00Price target, 12 to 18 months
2.5xEV / adjusted EBITDA, against 5.7x at end-2025
8.4%Free cash flow yield, no debt

Track record

Every call is tracked, losses included

Each edition compares our past calls with the Russell 2000 over the same days, whatever the result.

EditionTime since publicationOur four calls,
equal weighted
Russell 2000,
same days
Difference
October 1, 20266 weeks−17.5%−0.1%−17.4 pts
October 15, 20261 month−6.4%+2.3%−8.7 pts
November 1, 20262 weeks−5.6%−0.6%−5.0 pts

The horizon of every call is 12 to 18 months, and these editions are weeks old. We publish this table whether it flatters us or not, and we always will.

See the full track recordSubscription and pricing

Questions

Before you subscribe

Who is it for? Portfolio managers, investment advisers, family offices, traders and investors looking for researched ideas in US small and micro caps.
How is it delivered? By email, as a PDF, on the 1st and the 15th of each month, with a short note between editions after earnings or major events.
Can I stop at any time? Yes. Every payment is a one-time payment for the period chosen: nothing renews without your request.

General research, not personalized investment advice. Steven Dayan is not registered as an investment adviser, holds no position in the securities mentioned and receives no compensation from any issuer. All equity investment carries a risk of capital loss. Questions: steven@dayanresearch.fr.